A Study of LOR-253 HCl in Patients With Advanced or Metastatic Solid Tumours
Clinical trial NCT01281592 · COMPLETED
Trial details
- NCT number
- NCT01281592
- Sponsor
- Aptose Biosciences Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2013-07-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.